First Trust Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

First Trust Advisors’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,051,275	Closed	-$44.3M	–	2529
2023 Q2	$44.3M	Buy	1,051,275 +4,231	+0.4%	+$171K	0.05%	478
2023 Q1	$37.3M	Buy	1,047,044 +520,172	+99%	+$18.9M	0.04%	513
2022 Q4	$19.3M	Buy	526,872 +229,873	+77%	+$9.09M	0.02%	730
2022 Q3	$14M	Buy	296,999 +105,280	+55%	+$6.8M	0.02%	839
2022 Q2	$13.7M	Sell	191,719 -111,060	-37%	-$8.12M	0.02%	843
2022 Q1	$24.5M	Buy	302,779 +37,608	+14%	+$3.18M	0.03%	729
2021 Q4	$27.2M	Sell	265,171 -83,867	-24%	-$8.05M	0.03%	710
2021 Q3	$30.5M	Buy	349,038 +3,632	+1%	+$329K	0.03%	626
2021 Q2	$30.9M	Buy	345,406 +70,534	+26%	+$5.96M	0.03%	602
2021 Q1	$20.8M	Buy	274,872 +50,037	+22%	+$3.77M	0.03%	702
2020 Q4	$15.3M	Sell	224,835 -177,344	-44%	-$11.1M	0.02%	700
2020 Q3	$21.4M	Buy	402,179 +364,639	+971%	+$21.7M	0.03%	522
2020 Q2	$2.19M	Buy	37,540 +27,437	+272%	+$1.47M	﹤0.01%	1324
2020 Q1	$398K	Buy	+10,103	New	+$591K	﹤0.01%	2014
2019 Q4	–	Sell	-101,006	Closed	-$5.38M	–	2480
2019 Q3	$5.38M	Sell	101,006 -5,145	-5%	-$264K	0.01%	1027
2019 Q2	$5.42M	Buy	+106,151	New	+$4.94M	0.01%	1033
2019 Q1	–	Sell	-12,233	Closed	-$481K	–	2468
2018 Q4	$481K	Buy	12,233 +4,160	+52%	+$193K	﹤0.01%	2140
2018 Q3	$416K	Buy	8,073 +2,942	+57%	+$144K	﹤0.01%	2256
2018 Q2	$241K	Buy	+5,131	New	+$212K	﹤0.01%	2324
2018 Q1	–	Sell	-6,889	Closed	-$300K	–	2408
2017 Q4	$300K	Sell	6,889 -88,779	-93%	-$4.15M	﹤0.01%	2236
2017 Q3	$5M	Buy	95,668 +36,355	+61%	+$2.03M	0.01%	1032
2017 Q2	$3.47M	Sell	59,313 -9,831	-14%	-$511K	0.01%	1159
2017 Q1	$3.17M	Sell	69,144 -22,982	-25%	-$1.14M	0.01%	1245
2016 Q4	$4.85M	Buy	92,126 +42,398	+85%	+$2.05M	0.01%	1015
2016 Q3	$2.22M	Sell	49,728 -25,333	-34%	-$1.1M	0.01%	1283
2016 Q2	$2.86M	Buy	75,061 +46,025	+159%	+$2.02M	0.01%	1130
2016 Q1	$1.2M	Sell	29,036 -11,917	-29%	-$491K	﹤0.01%	1589
2015 Q4	$1.99M	Buy	40,953 +236	+0.6%	+$10.5K	0.01%	1402
2015 Q3	$1.63M	Buy	40,717 +3,222	+9%	+$141K	﹤0.01%	1498
2015 Q2	$1.5M	Buy	+37,495	New	+$1.29M	﹤0.01%	1653

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

First Trust Advisors's SYNH Position: Q3 2023 in Review

First Trust Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 1,051,275 shares — an estimated $44.3M sold.

First Trust Advisors first reported a position in SYNH in Q2 2015 and held it in 30 quarters. The position peaked at $44.3M in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

First Trust Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
First Trust Advisors sold 1,051,275 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $44.3M.
First Trust Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2015 and held it in 30 quarters.
First Trust Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $44.3M in Q2 2023.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on First Trust Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.